Onyx Therapeutics, Inc. v. Apotex Inc. et al > Documents
Date Field | Doc. No. | Description (Pages) |
---|---|---|
Jul 8, 2020 | 1 | Complaint (25) |
May 8, 2019 | 13 | Order (3) Docket Text: CONSENT JUDGMENT as to Apotex, ***Civil Case Terminated. Signed by Judge Leonard P. Stark on 5/7/19. Associated Cases: 1:16-cv-01039-LPS, 1:17-cv-01202-LPS, 1:18-cv-00132-LPS (ntl) |
May 4, 2019 | 12 | Proposed Consent Judgment (3) Docket Text: PROPOSED CONSENT JUDGMENT Between Onyx Therapeutics, Inc. and Apotex Inc. & Apotex Corp. by Onyx Therapeutics, Inc.. (Dellinger, Megan) |
Sep 15, 2017 | 10 | Answer to Complaint (30) Docket Text: ANSWER to [1] Complaint, Answer and Affirmative Defenses to Plaintiff's Complaint by Apotex Corp., Apotex Inc..(Bellew, Joseph) |
Sep 15, 2017 | 11 | Disclosure Statement (1) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Apotex Holdings, Inc. for Apotex Corp., Apotex Inc. filed by Apotex Corp., Apotex Inc.. (Bellew, Joseph) |
Sep 14, 2017 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (9 in 1:17-cv-01202-LPS, 9 in 1:17-cv-01155-LPS, 8 in 1:17-cv-01235-LPS) Stipulation and Order to Consolidate with lead case no. 16-988-LPS. ALL FILINGS SHALL BE MADE IN LEAD CASE NO. 16-988-LPS. Signed by Judge Leonard P. Stark on 9/14/17. Associated Cases: 1:17-cv-01155-LPS, 1:17-cv-01202-LPS, 1:17-cv-01235-LPS (ntl) |
Sep 14, 2017 | N/A | Create Case Association (0) Docket Text: Case associated with lead case: Create association to 1:16-cv-00988-LPS. (ntl) |
Sep 13, 2017 | 9 | Stipulation (3) Docket Text: STIPULATION and [Proposed] Order to Consolidate by InnoPharma Inc.. (Bilson, David) |
Aug 30, 2017 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Assigned to Judge Leonard P. Stark. Please include the initials of the Judge (LPS) after the case number on all documents filed. (rjb) |
Aug 29, 2017 | 8 | Notice of Appearance (1) Docket Text: NOTICE of Appearance by Joseph James Bellew on behalf of Apotex Corp., Apotex Inc. (Bellew, Joseph) |
Aug 25, 2017 | N/A | Summons Issued (0) Docket Text: Summons Issued with Magistrate Consent Notice attached as to Apotex Corp. on 8/25/2017; Apotex Inc. on 8/25/2017. Requesting party or attorney should pick up issued summons at the Help Desk, Room 4209, or call 302-573-6170 and ask the Clerk to mail the summons to them. (nmfn) |
Aug 25, 2017 | 6 | Summons Returned Executed (2) Docket Text: SUMMONS Returned Executed by Onyx Therapeutics, Inc.. Apotex Inc. served on 8/25/2017, answer due 9/15/2017. (Noreika, Maryellen) |
Aug 25, 2017 | 7 | Summons Returned Executed (2) Docket Text: SUMMONS Returned Executed by Onyx Therapeutics, Inc.. Apotex Corp. served on 8/25/2017, answer due 9/15/2017. (Noreika, Maryellen) |
Aug 24, 2017 | 1 | Exhibits A-H (308) |
Aug 24, 2017 | 1 | Civil Cover Sheet (2) |
Aug 24, 2017 | 2 | Magistrate Consent Forms (3) Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (nmfn) |
Aug 24, 2017 | 3 | ANDA Form (1) Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 7/21/2017. Date of Expiration of Patent: 7,417,042 - July 20, 2026; 7,232,818 - April 14, 2025; 8,207,126 - April 14, 2025; 7,491,704 - April 14, 2025; 8,207,127 - April 14, 2025; 8,129,346 - April 14, 2025; 8,207,297 - April 14, 2025; 8,207,125 - April 14, 2025. Thirty Month Stay Deadline: 1/21/2020. (nmfn) |
Aug 24, 2017 | 4 | Patent/Trademark Report to Commissioner (2) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,417,042 B2; 7,232,818 B2; 7,491,704 B2; 8,129,346 B2; 8,207,125 B2; 8,207,126 B2; 8,207,127 B2; 8,207,297 B2. (nmfn) |
Aug 24, 2017 | 5 | Disclosure Statement (1) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Amgen Inc., Corporate Parent Onyx Pharmaceuticals, Inc. for Onyx Therapeutics, Inc. filed by Onyx Therapeutics, Inc. (nmfn) |
Aug 24, 2017 | 1 | Main Document (25) Docket Text: COMPLAINT FOR PATENT INFRINGEMENT filed against Apotex Inc., Apotex Corp. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2210299.) - filed by Onyx Therapeutics, Inc. (Attachments: # (1) Exhibits A-H, # (2) Civil Cover Sheet)(nmfn) |